Here we observed that selective depletion of excessive α-SMA+DR5+ MFBs accumulated in areas of fibrosis by externally supplied DR5 agonists, TLY012 and anti-DR5 antibody, reversed skin fibrosis to near-normal skin architecture without notable toxicity in animal models with active, progressive skin fibrosis. Here, TNFRSF10B is linked to fibrosis.